These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25249047)

  • 1. Comment on: prescribing of rosiglitazone and pioglitazone following safety signals analysis of trends in dispensing patterns in The Netherlands from 1998 to 2008.
    Carracedo-Martínez E
    Drug Saf; 2014 Dec; 37(12):1069-70. PubMed ID: 25249047
    [No Abstract]   [Full Text] [Related]  

  • 2. Author's reply to Carracedo-Martínez E comment on: "prescribing of rosiglitazone and pioglitazone following safety signals: analysis of trends in dispensing patterns in The Netherlands from 1998 to 2008".
    Stricker BH
    Drug Saf; 2014 Dec; 37(12):1071. PubMed ID: 25249048
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescribing of rosiglitazone and pioglitazone following safety signals: analysis of trends in dispensing patterns in the Netherlands from 1998 to 2008.
    Ruiter R; Visser LE; van Herk-Sukel MP; Geelhoed-Duijvestijn PH; de Bie S; Straus SM; Mol PG; Romio SA; Herings RM; Stricker BH
    Drug Saf; 2012 Jun; 35(6):471-80. PubMed ID: 22540371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing pattern of glucose lowering drugs in the United Kingdom in the last decade: a focus on the effects of safety warnings about rosiglitazone.
    Leal I; Romio SA; Schuemie M; Oteri A; Sturkenboom M; Trifirò G
    Br J Clin Pharmacol; 2013 Mar; 75(3):861-8. PubMed ID: 22845019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013.
    Clemens KK; Liu K; Shariff S; Schernthaner G; Tangri N; Garg AX
    Diabetes Obes Metab; 2016 Jun; 18(6):607-14. PubMed ID: 26939711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes and predictors for change to thiazolidinedione prescribing in UK primary care following the rosiglitazone safety warning.
    Hall GC; Smith HT; Curtis B; McMahon AD
    Int J Clin Pract; 2011 May; 65(5):586-91. PubMed ID: 21489082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of new insights and revised practice guidelines on prescribing drugs in the treatment of Type 2 diabetes mellitus.
    Lub R; Denig P; van den Berg PB; Hoogenberg K; de Jong-van den Berg LT
    Br J Clin Pharmacol; 2006 Dec; 62(6):660-5. PubMed ID: 16796700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type 2 diabetes mellitus patients and yearly changes in diabetologists' prescribing patterns from 2002 to 2019 (JDDM61).
    Yagi N; Komiya I; Arai K; Oishi M; Fukumoto Y; Shirabe S; Yokoyama H; Yamazaki K; Sugimoto H; Maegawa H;
    J Diabetes Investig; 2022 Jan; 13(1):65-73. PubMed ID: 34191401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilisation trends of rosiglitazone and pioglitazone in Australia before and after safety warnings.
    Niyomnaitham S; Page A; La Caze A; Whitfield K; Smith AJ
    BMC Health Serv Res; 2014 Apr; 14():151. PubMed ID: 24708579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic Variation in Rosiglitazone Use Surrounding FDA Warnings in the Department of Veterans Affairs.
    Ahuja V; Sohn MW; Birge JR; Syverson C; Budiman-Mak E; Emanuele N; Cooper JM; Huang ES
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1214-34. PubMed ID: 26679970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the prescription of antidiabetic medications in France: evidence from primary care physicians.
    Boyc KS; Yurgin N; Lage MJ
    Adv Ther; 2007; 24(4):803-13. PubMed ID: 17901029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the sitagliptin alert on prescription of oral antihyperglycemic drugs in Japan.
    Sato D; Sato Y; Masuda S; Kimura H
    Int J Clin Pharm; 2012 Dec; 34(6):917-24. PubMed ID: 22941471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in glitazone use among office-based physicians in the U.S., 2003-2009.
    Cohen A; Rabbani A; Shah N; Alexander GC
    Diabetes Care; 2010 Apr; 33(4):823-5. PubMed ID: 20103549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlicensed use of metformin in children and adolescents in Germany and France.
    Kostev K; Richter H
    Br J Clin Pharmacol; 2012 Feb; 73(2):307-8. PubMed ID: 22023105
    [No Abstract]   [Full Text] [Related]  

  • 15. BASAL INSULIN 4.0: UPDATING YOUR CLINICAL PRACTICE WITH ULTRALONG-ACTING INSULINS AND INSULIN COMBINATION THERAPY.
    Endocr Pract; 2016 Nov; 22(Suppl 5):1-25. PubMed ID: 27849359
    [No Abstract]   [Full Text] [Related]  

  • 16. Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs.
    Colhoun HM; Livingstone SJ; Looker HC; Morris AD; Wild SH; Lindsay RS; Reed C; Donnan PT; Guthrie B; Leese GP; McKnight J; Pearson DW; Pearson E; Petrie JR; Philip S; Sattar N; Sullivan FM; McKeigue P;
    Diabetologia; 2012 Nov; 55(11):2929-37. PubMed ID: 22945303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply to: 'Glaucoma prescribing trends in England 2000 to 2012'.
    Tiew S; Choudhary A
    Eye (Lond); 2015 Jan; 29(1):147-8. PubMed ID: 25277301
    [No Abstract]   [Full Text] [Related]  

  • 18. Temporal trends in anti-diabetes drug use in TRICARE following safety warnings in 2007 about rosiglitazone.
    Stewart KA; Natzke BM; Williams T; Granger E; Casscells SW; Croghan TW
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1048-52. PubMed ID: 19655338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycaemia with oral antidiabetic drugs: results from prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide.
    Vlckova V; Cornelius V; Kasliwal R; Wilton L; Shakir SA
    Drug Saf; 2009; 32(5):409-18. PubMed ID: 19419235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17.
    Heald AH; Livingston M; Bien Z; Moreno GYC; Laing I; Stedman M
    Int J Clin Pract; 2018 Apr; 72(4):e13080. PubMed ID: 29537664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.